Dow Up 0.00% Nasdaq Up 0.09%

PDL BioPharma, Inc. (PDLI)

-NasdaqGS
8.26 Up 0.12(1.47%) Nov 28, 1:00PM EST
Prev Close:8.14
Open:8.15
Bid:5.13 x 100
Ask:N/A
1y Target Est:8.00
Beta:0.61
Next Earnings Date:N/A
Day's Range:8.10 - 8.28
52wk Range:7.22 - 10.26
Volume:1,294,262
Avg Vol (3m):3,110,300
Market Cap:1.33B
P/E (ttm):4.19
EPS (ttm):1.97
Div & Yield:0.60 (7.40%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PDLI

Comparison

Symbol% ChgMkt Cap
PDLIUp 1.47%1.33B
AMGNUp 0.36%125.75B
SGENDown 0.95%4.51B
XOMADown 0.18%611.07M

Key Statistics

Forward P/E (1 yr):3.81
P/S (ttm):2.81
Ex-Dividend Date:03-Dec-14

Analysts

Annual EPS Est (Dec-14) :2.15
Quarterly EPS Est (Dec-14) :0.57
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):0.27

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PDL BioPharma, Inc. manages a portfolio of patents and royalty assets. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback